High-dose therapy with ropinirole in patients with Parkinson's disease

Journal of Neural Transmission

Volumn 108, Issue 11, 2001, Pages 1309-1317

  Mungersdorf M ^a   Sommer, U ^a   Sommer, M ^b   Reichmann, H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Dopamine agonist; Dyskinesias; High dose therapy; Motor fluctuations; Parkinson's disease; Ropinirole

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BIPERIDEN; ENTACAPONE; LEVODOPA; PERGOLIDE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; OUTCOMES RESEARCH; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DYSKINESIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 0035212184     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020100007     Document Type: Article

References (30)

1. Ropinirole for the treatment of early Parkinson's disease
2. Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline
3. Pergolide monotherapy in the treatment of early Parkinson's disease
4. Pathophysiology of L-dopa-induced dyskinesias
5. Ropinirole in the symptomatic treatment of Parkinsons disease
6. Sixteen-year follow-up of 100 patients begun on levodopa in 1968: Emerging problems
7. Levodopa therapy: Consequences of nonphysiologic replacement of dopamine
8. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias
9. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
10. Risk factors for levodopa-induced dyskinesias in Parkinson's disease
11. The Sydney Multicentre Study of Parkinson's disease: A randomised, prospectivefive year study comparing low dose bromocriptine with low dose levodopa-carbidopa
12. Ropinirole and pramipexole, the new agonists
13. Pramipexole versus levodopa in early Parkinson's disease: A randomized clinical trial
14. Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease
15. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease
16. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease
17. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease
18. Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what
19. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: A five year follow up
20. Levodopa-induced dyskinesia: Review, observations, and speculations
21. Motor complications associated with chronic levodopa therapy in Parkinson's disease
22. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
23. Effects of repeated treatment with L-dopa, bromocriptine and ropinirole in drug-naive MPTP-treated common marmosets
24. Should treatment of Parkinson's disease be started with a dopamine agonist?
25. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
26. Drug treatment guidelines for the long-term management of Parkinson's disease
27. Combined bromocriptine-levodopa therapy early in Parkinson's disease
28. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease
29. Young-onset Parkinson's disease revisited - Clinical features, natural history, and mortality
30. Improvement of motorfluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa